# Astrazeneca Sweden Investments (Astrazeneca Sweden Investments Limited)

Private limited company registered in Cambridge, classed under “Other business support service activities n.e.c.”.

- Company number: 04726837
- Status: Active
- Type: Private limited company
- Incorporated: 8 April 2003
- Registered office: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA
- Location: Cambridge
- Activity: Other business support service activities n.e.c.

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Astrazeneca Sweden Investments do?

Private limited company registered in Cambridge, classed under “Other business support service activities n.e.c.”.

### How much turnover does Astrazeneca Sweden Investments make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/astrazeneca-sweden-investments-04726837

### Is Astrazeneca Sweden Investments profitable?

Astrazeneca Sweden Investments's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Astrazeneca Sweden Investments?

Its directors are Camilla Johnstone, Yvonne Louise Bertlin, Iain Alistair Collins, Jonathan Thomas Charles Slade. Its owners are shown to subscribers.

### Where is Astrazeneca Sweden Investments based?

Its registered office is 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, in Cambridge.

### When was Astrazeneca Sweden Investments founded?

Astrazeneca Sweden Investments Limited was incorporated on 8 April 2003.

### Is Astrazeneca Sweden Investments still trading?

The register lists Astrazeneca Sweden Investments Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-06-21: Full accounts made up to 31 December 2025
- 2025-06-02: Full accounts made up to 31 December 2024
- 2025-05-01: Appointment of Camilla Johnstone as a secretary on 1 May 2025
- 2025-05-01: Termination of appointment of Matthew Shaun Bowden as a secretary on 1 May 2025
- 2024-11-27: Memorandum and Articles of Association
- 2024-11-27: Resolutions (and 3 more like it since 8 March 2006)
- 2024-05-23: Full accounts made up to 31 December 2023
- 2023-07-04: Full accounts made up to 31 December 2022
- 2022-07-15: Full accounts made up to 31 December 2021
- 2021-08-13: Full accounts made up to 31 December 2020
- 2020-11-30: Full accounts made up to 31 December 2019
- 2019-09-16: Full accounts made up to 31 December 2018
- 2019-03-14: Appointment of Matthew Shaun Bowden as a secretary on 27 February 2019
- 2019-03-08: Termination of appointment of Katie Louise Jackson-Turner as a secretary on 27 February 2019
- 2018-10-30: Appointment of Yvonne Louise Bertlin as a director on 27 September 2018
- 2018-10-04: Full accounts made up to 31 December 2017
- 2018-09-05: Termination of appointment of Jan-Olof Jacke as a director on 31 August 2018
- 2018-07-09: Appointment of Jonathan Thomas Charles Slade as a director on 20 June 2018
- 2018-01-08: Termination of appointment of Brendan James Boucher as a director on 31 December 2017
- 2017-09-30: Full accounts made up to 31 December 2016
- 2017-08-07: Secretary's details changed for Katie Louise Jackson-Turner on 1 May 2016
- 2017-06-13: Appointment of Iain Alistair Collins as a director on 31 May 2017
- 2017-06-01: Termination of appointment of Ian Martin David Brimicombe as a director on 31 May 2017
- 2017-02-27: Director's details changed for Mr Brendan James Boucher on 1 May 2016
- 2016-08-22: Full accounts made up to 31 December 2015

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/astrazeneca-sweden-investments-04726837